XML 118 R89.htm IDEA: XBRL DOCUMENT v3.24.0.1
Shareholders Equity - Restricted stock unit (Details)
$ in Millions
 12 Months Ended
Dec. 31, 2023
USD ($)
EquityInstruments
Dec. 31, 2022
USD ($)
EquityInstruments
Stock-based payments    
Number of other equity instruments outstanding in share-based payment arrangement at beginning of period 102,104  
Number of other equity instruments outstanding in share-based payment arrangement at end of period 102,104 102,104
Restricted Share Units    
Stock-based payments    
Number of other equity instruments outstanding in share-based payment arrangement at beginning of period 102,104 98,894
Granted   53,129
Settled   (49,919)
Number of other equity instruments outstanding in share-based payment arrangement at end of period 102,104 102,104
Fair value of RSUs granted | $ $ 0.0 $ 7.9
Stock-based compensation expenses | $ 4.1 6.4
Capitalised to royalty, stream and working interest | $ 0.2 0.2
Total unrecognized non-cash stock-based compensation expense | $ $ 5.2 $ 9.4
Expected to be recognized over weighted average period 1 year 8 months 12 days 2 years 2 months 12 days
Performance based RSU    
Stock-based payments    
Number of other equity instruments outstanding in share-based payment arrangement at beginning of period 71,051 66,794
Granted   37,486
Settled   (33,229)
Number of other equity instruments outstanding in share-based payment arrangement at end of period 71,051 71,051
Time-based RSU    
Stock-based payments    
Number of other equity instruments outstanding in share-based payment arrangement at beginning of period 31,053 32,100
Granted   15,643
Settled   (16,690)
Number of other equity instruments outstanding in share-based payment arrangement at end of period 31,053 31,053